Endogenous dopamine release in the human brain as a pharmacodynamic biomarker: evaluation of the new GPR139 agonist TAK-041 with [(11)C]PHNO PET

The use of positron emission tomography (PET) in early-phase development of novel drugs targeting the central nervous system, is well established for the evaluation of brain penetration and target engagement. However, when novel targets are involved a suitable PET ligand is not always available. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Rabiner, Eugenii A., Uz, Tolga, Mansur, Ayla, Brown, Terry, Chen, Grace, Wu, Jingtao, Atienza, Joy, Schwarz, Adam J., Yin, Wei, Lewis, Yvonne, Searle, Graham E., Dennison, Jeremy M. T. J., Passchier, Jan, Gunn, Roger N., Tauscher, Johannes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117280/
https://www.ncbi.nlm.nih.gov/pubmed/34675381
http://dx.doi.org/10.1038/s41386-021-01204-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117280/
https://www.ncbi.nlm.nih.gov/pubmed/34675381
http://dx.doi.org/10.1038/s41386-021-01204-1

Ejemplares similares